-
COST-EFFECTIVENESS AND BUDGET IMPACT OF CAFFEINE CITRATE VERSUS AMINOPHYLLINE FOR APNEA OF PREMATURITY ACROSS A PUBLIC HEALTHCARE SYSTEM IN MEXICO
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS AND SAFETY OF EAST ASIAN TRADITIONAL MEDICINE FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN CHILDREN: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT-REPORTED OUTCOMES IN UNITED STATES PROMOTIONAL COMMUNICATIONS FOR DRUGS AND BIOLOGICS: A REVIEW OF DRUG PROMOTION UNTITLED LETTERS FROM THE FDA
Mar 18, 2026, 21:38 PM -
THE ROLE OF SAFETY AND TOLERABILITY IN HTA VALUE ASSESSMENT: EVIDENCE REQUIREMENTS AND IMPACT ACROSS KEY EUROPEAN MARKETS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS ANALYSIS OF FOLFIRINOX AND GEMCITABINE PLUS NAB-PACLITAXEL IN METASTATIC PANCREATIC ADRENOCARCINOMA; USING MARGINAL STRUCTURAL MODEL
Mar 18, 2026, 21:38 PM -
ASSESSING QUALITY OF A LARGE LANGUAGE MODEL (LLM)-DERIVED PROSTATE CANCER (PC) REAL-WORLD DATASET: AN APPLICATION OF THE VALIDATION OF ACCURACY FOR LLM/ML-EXTRACTED INFORMATION AND DATA (VALID) FRAMEWORK
Mar 18, 2026, 21:38 PM -
THE MARKET FOR MONOCLONAL ANTIBODIES: TRENDS, CHALLENGES, AND OPPORTUNITIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE (RWE) ON BRUTON TYROSINE KINASE INHIBITORS (BTKIS) IN TREATMENT-NAIVE (TN) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL): AN ARTIFICIAL INTELLIGENCE (AI)-ASSISTED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN ALCOHOL USE DISORDER IDENTIFICATION MODEL USING ELECTRONIC HEALTH RECORD-DERIVED FEATURES FOR CLINICAL IMPLEMENTATION
Mar 18, 2026, 21:38 PM -
COST-OF-ILLNESS OF PNEUMONIA, BACTEREMIA OR MENINGITIS IN COLOMBIAN ADULTS: A RETROSPECTIVE DATABASE STUDY, 2015 TO 2022
Mar 18, 2026, 21:38 PM -
SAFETY OF BRAND-NAME INFLIXIMAB VERSUS BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE: REAL-WORLD EVIDENCE FROM U.S. CLAIMS DATA
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE COSTS OF DIFFUSE LARGE B-CELL LYMPHOMA IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
TRENDS IN UTILIZATION AND OUT-OF-POCKET SPENDING FOR GLP-1 RECEPTOR AGONISTS AMONG U.S. ADULTS WITH TYPE 2 DIABETES, 2018-2023: A MEPS STUDY
Mar 18, 2026, 21:38 PM -
BARRIERS TO RECOVERY AND THE ASSOCIATION BETWEEN SHARED DECISION-MAKING AND RETENTION IN CARE AMONG PERINATAL WOMEN WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
Mar 18, 2026, 21:38 PM -
IMPACT OF PULMONARY ARTERIAL HYPERTENSION ON HEART-LUNG TRANSPLANTATION OUTCOMES AND COSTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
EVALUATING CLINICAL OUTCOME ASSESSMENTS IN LOW-RISK MYELODYSPLASTIC SYNDROMES THROUGH DEVELOPMENT OF A COMPREHENSIVE CONCEPTUAL MODEL BASED ON TARGETED LITERATURE REVIEWS AND CLINICIAN INTERVIEWS
Mar 18, 2026, 21:38 PM -
EXPLORATORY APPLICATION OF BIVARIATE NETWORK META-ANALYSIS TO PREDICT MISSING HAZARD RATIOS IN MCRPC USING SIMULATED CORRELATION DATA
Mar 18, 2026, 21:38 PM -
UNANCHORED MAIC VS STC FOR BINARY OUTCOMES: HOW BASELINE IMBALANCE IMPACTS ORR ESTIMATES
Mar 18, 2026, 21:38 PM -
THE FEASIBILITY OF MEASURING BTKI MEDICATION ADHERENCE IN THE TREATMENT OF CLL/SLL USING AN ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) PLATFORM
Mar 18, 2026, 21:38 PM
